Entropy Technologies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
+24,338
New +$235K 0.01% 754
2026
Q1
Sell
-23,037
Closed -$271K 1069
2025
Q4
$271K Buy
23,037
+1,480
+7% +$16K 0.01% 731
2025
Q3
$166K Buy
21,557
+5,167
+32% +$36.2K 0.01% 764
2025
Q2
$120K Buy
+16,390
New +$132K 0.01% 739

Other funds holding NEO

Entropy Technologies's NEO Position: Q2 2026 in Review

Entropy Technologies opened a new position in NeoGenomics (NEO) in Q2 2026: 24,338 shares worth $355K. The stake represents 0.01% of the portfolio and ranks #754 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in NEO as recently as Q4 2025.

Entropy Technologies first reported a position in NEO in Q2 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Entropy Technologies held 24,338 shares of NeoGenomics worth $355K as of Q2 2026.
  • NeoGenomics was a new Entropy Technologies position in Q2 2026.
  • NeoGenomics made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #754 holding.
  • Entropy Technologies first reported a position in NeoGenomics in Q2 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.